Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pere Santamaria

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
The American Journal of Pathology|June 7, 2011
Autoreactive cytotoxic T lymphocytes acquire higher expression of cytotoxic effector markers in the islets of NOD mice after priming in pancreatic lymph nodesKate L Graham, Balasubramanian Krishnamurthy, Stacey Fynch, et al.
The Review of Diabetic Studies : RDS|November 10, 2010
Turning human epidermis into pancreatic endodermPere Santamaria, Ignacio Rodriguez-Piza, Xavier Clemente-Casares, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 29, 2014
The cross-priming capacity and direct presentation potential of an autoantigen are separable and inversely related propertiesJinguo Wang, Roopa Hebbandi Nanjundappa, Afshin Shameli, et al.
Immunity|April 13, 2010
Reversal of autoimmunity by boosting memory-like autoregulatory T cellsSue Tsai, Afshin Shameli, Jun Yamanouchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Reversal of autoimmunity by mixed chimerism enables reactivation of β cells and transdifferentiation of α cells in diabetic NOD miceShanshan Tang, Mingfeng Zhang, Samuel Zeng, et al.
Diabetes|November 2, 2011
Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulationVitaly Ablamunits, Octavian Henegariu, Jakob Bondo Hansen, et al.
Clinical Immunology (Orlando, Fla.)|December 25, 2002
During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificitiesTeresa P DiLorenzo, Scott M Lieberman, Toshiyuki Takaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
IL-1 beta breaks tolerance through expansion of CD25+ effector T cellsBrendan J O'Sullivan, Helen E Thomas, Saparna Pai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2026
Islet-derived T cells from both mice and humans recognize conserved insulin A-chain peptides presented by HLA-C*03:04Nitin Amdare, Riyasat Ali, Anthony Manganaro, et al.
The Journal of Clinical Investigation|January 18, 2003
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral bloodJacqueline D Trudeau, Carolyn Kelly-Smith, C Bruce Verchere, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
The American Journal of Pathology|June 7, 2011
Autoreactive cytotoxic T lymphocytes acquire higher expression of cytotoxic effector markers in the islets of NOD mice after priming in pancreatic lymph nodesKate L Graham, Balasubramanian Krishnamurthy, Stacey Fynch, et al.
The Review of Diabetic Studies : RDS|November 10, 2010
Turning human epidermis into pancreatic endodermPere Santamaria, Ignacio Rodriguez-Piza, Xavier Clemente-Casares, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 29, 2014
The cross-priming capacity and direct presentation potential of an autoantigen are separable and inversely related propertiesJinguo Wang, Roopa Hebbandi Nanjundappa, Afshin Shameli, et al.
Immunity|April 13, 2010
Reversal of autoimmunity by boosting memory-like autoregulatory T cellsSue Tsai, Afshin Shameli, Jun Yamanouchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Reversal of autoimmunity by mixed chimerism enables reactivation of β cells and transdifferentiation of α cells in diabetic NOD miceShanshan Tang, Mingfeng Zhang, Samuel Zeng, et al.
Diabetes|November 2, 2011
Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulationVitaly Ablamunits, Octavian Henegariu, Jakob Bondo Hansen, et al.
Clinical Immunology (Orlando, Fla.)|December 25, 2002
During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificitiesTeresa P DiLorenzo, Scott M Lieberman, Toshiyuki Takaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
IL-1 beta breaks tolerance through expansion of CD25+ effector T cellsBrendan J O'Sullivan, Helen E Thomas, Saparna Pai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2026
Islet-derived T cells from both mice and humans recognize conserved insulin A-chain peptides presented by HLA-C*03:04Nitin Amdare, Riyasat Ali, Anthony Manganaro, et al.
The Journal of Clinical Investigation|January 18, 2003
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral bloodJacqueline D Trudeau, Carolyn Kelly-Smith, C Bruce Verchere, et al.
Pageof 16